Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
drugs
7
×
clinical trials
life sciences
national blog main
fda
boston blog main
boston top stories
national top stories
new york blog main
new york top stories
indiana blog main
indiana top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
biotech
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
eli lilly
merck
national
pfizer
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
4d molecular therapeutics
abbvie
acne
agenus
akcea therapeutics
allopregnanolone
What
approved
7
×
drug
fda
medicine
new
oks
ago
battle
disease
genetic
marijuana
medicines
rare
sets
akcea
alcohol
alnylam
amyloidosis
announced
approval
attr
available
bio
brexanolone
cancer
cannabis
class
companies
data
debilitating
decision
deeper
dependence
depression
derivative
devastating
developed
digital
disorder
dna
Language
Current search:
approved
×
drugs
×
@xconomy.com
4 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
5 years ago
Zogenix Epilepsy Data Sets Up Market Battle With GW’s Cannabis Drug
@theverge.com
7 years ago
Medical marijuana doesn’t make for more teenage stoners